Understanding Resistance to Emamectin Benzoate in Salmon Lice
Author Information
Author(s): Armin Sturm, Greta Carmona-Antoñanzas, Joseph L. Humble, Claudia Croton, Sally Boyd, Rapule Mphuti, John B. Taggart, David I. Bassett, Ross D. Houston, Karim Gharbi, James E. Bron, Michaël Bekaert
Primary Institution: Institute of Aquaculture, University of Stirling, Stirling, Scotland, UK
Hypothesis
The study aims to identify genetic and transcriptomic markers associated with emamectin benzoate resistance in salmon lice.
Conclusion
The study found that major determinants of emamectin benzoate resistance in salmon lice are located on Chromosome 5, and resistance can be predicted using a limited number of genetic markers.
Supporting Evidence
- Resistance to emamectin benzoate is widespread in Atlantic populations of L. salmonis.
- One quantitative trait locus (QTL) region on Chromosome 5 is associated with EMB resistance.
- Seven SNPs were confirmed to be associated with EMB susceptibility through genotyping assays.
Takeaway
Scientists are trying to figure out why some salmon lice don't get sick from a medicine that usually works against them, and they found some important clues in their genes.
Methodology
The study involved genetic crosses between emamectin-susceptible and resistant salmon lice, followed by phenotyping using time-to-response bioassays and sequencing for SNP discovery.
Limitations
The study may not account for all genetic factors influencing resistance, and the findings are based on specific strains of salmon lice.
Participant Demographics
The study focused on salmon lice sourced from two parental strains isolated in Scotland.
Statistical Information
P-Value
3.33×10−28
Confidence Interval
95%
Statistical Significance
p<3.33×10−28
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website